Last reviewed · How we verify

PYRIDOXAL

FDA-approved active Small molecule Quality 10/100

PYRIDOXAL is a Vitamin C [EPC] drug. It is currently FDA-approved.

At a glance

Generic namePYRIDOXAL
Drug classVitamin C [EPC]
TargetAldehyde oxidase
ModalitySmall molecule
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

Serious adverse events

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about PYRIDOXAL

What is PYRIDOXAL?

PYRIDOXAL is a Vitamin C [EPC] drug.

What drug class is PYRIDOXAL in?

PYRIDOXAL belongs to the Vitamin C [EPC] class. See all Vitamin C [EPC] drugs at /class/vitamin-c-epc.

What development phase is PYRIDOXAL in?

PYRIDOXAL is FDA-approved (marketed).

What are the side effects of PYRIDOXAL?

Common side effects of PYRIDOXAL include Mild transient diarrhea, Itching, Transitory exanthema, Feeling of swelling of entire body. Serious adverse events: Polycythemia vera, Allergic sensitization.

What does PYRIDOXAL target?

PYRIDOXAL targets Aldehyde oxidase and is a Vitamin C [EPC].

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing